Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania

BMC Pediatrics

Volumn 13, Issue 1, 2013, Pages

  Mghamba, Frida William ^a   Minzi, Omary M S ^a   Massawe, Augustine ^a   Sasi, Philip ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG COMBINATION; LAMIVUDINE; STAVUDINE; STAVUDINE, LAMIVUDINE, NEVIRAPINE DRUG COMBINATION; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DRUG BLOOD LEVEL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MOUTH LESION; OTITIS MEDIA; PATIENT COMPLIANCE; PNEUMONIA; PRESCHOOL CHILD; SCHOOL CHILD; SKIN DEFECT; STRUCTURED QUESTIONNAIRE; TANZANIA; ADULT; AGED; BLOOD; DRUG ADMINISTRATION; DRUG COMBINATION; HIV INFECTIONS; IMMUNOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; QUESTIONNAIRE; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CAREGIVERS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEVIRAPINE; ODDS RATIO; QUESTIONNAIRES; STAVUDINE; TANZANIA; YOUNG ADULT; ZIDOVUDINE;

EID: 84878894740     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-13-95     Document Type: Article

References (22)

1. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Volberding PA. Antiretroviral therapy in adult. J Am Med Assoc 2000, 283(3):381-390.
2. Paterson DL, Swindells S, Mohr J, Brester M, Singh N. Adherence to protease inhibitor therapy and outcome in patient with HIV infection. Ann Intern Med 2000, 133(1):21-30.
3. Eley B, Nuttall J, Davies MA, Smith L, Cowburn C, Hussey G. Initial experience of public sector antiretroviral treatment program for HIV-Infected children and their infected parents. South African Med J 2004, 94(8):643-646.
4. Reddington C, Cohen J, Buldillo A, Toye M, Smith D, Hsu HW. Adherence to medication regimen among children with Human immunodeficiency virus. Pediatr Infect Dis J 2000, 19(12):1148-1153. 10.1097/00006454-200012000-00005, 11144374.
5. Gibb DM, Goodall RL, Giacomet V, McGee L, Compaqnucci A, Lyall H, Peadiatric European Network for Treatment of AIDS Steering Committee Adherence to prescribed antiretroviral therapy in human immunodeficiency virus- infected children PENTA 5 trial. Pediatr Infect Dis J 2003, 22(1):56-62. 10.1097/00006454-200301000-00015, 12544410, Peadiatric European Network for Treatment of AIDS Steering Committee.
6. La Greca AM, Schuman WB. Adherence to prescribed medication regime. Handbook of paediatric psychology. 1995, 55-83. New York: Guilford press.
7. Elise A, Anaky M, Wemin M, Rouet F, Salamon R, Msellati P. Assessment of adherence to highly active retroviral therapy in African HIV infected children. J AIDS 2005, 40(4):498-500.
8. Pontali E. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection. Paediatric Drugs 2005, 7(3):137-149. 10.2165/00148581-200507030-00001, 15977960.
9. Quitter AL, Espelage DL, Drotar D. Measuring adherence to medical treatment in childhood chronic illness. J Clin Psychol Med Settings 2000, 7:41-54.
10. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. J AIDS 1999, 13(Suppl A):S272-S278.
11. Kouanfack C, Laurent C, Peytavin G, Caffi L, Ngolle M, Nkene YM, Koulla-Shiro S. Adherence to antiretroviral therapy assessed by the drug level in Cameroon. J Acquir Immune Defic Syndr 2008, 48(2):216-219. 10.1097/QAI.0b013e3181743955, 18520681.
12. Sibhatu B, Amare D, Alemayehu A, Kebede D, Adugaw B. Discordance between provider estimate and caregiver self report adherence to HAART and immunological response. Int J Health Res 2009, 2(2):139-148.
13. David MA, Boulle A, Fakir A, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town measured by medication return. BMC Paediatric 2008, 8:34.
14. Gravie PA, Wilkins ML, Young JC. Medication adherence in Adolescents with behaviourally -acqured HIV: evidenced for using a multmethod using multiple method assessment protocol. J Adolesc Health 2010 Nov, 47(5):504-511.
15. Agarwal D, Chakravarty J, Sunder S, Gupta V, Bhatia BD. Correlation between clinical features and degree of immunosuppression in HIV infected children. Indian Paediatr J 2008, 45(2):140-143.
16. Chakravarty J, Mehta H, Parekh A, Attil SV, Agrawal NR, Singh SP, Sunder S. Clinical epidemiological profile of HIV patient in eastern India. J Assoc Phys India 2006, 54:854-857.
17. National Aids Control Program: Tanzania National guideline for the clinical management of HIV and AIDS. Third edition revised February 2009, [http://www.who.int/hiv/pub/guideline/tanzania_art.pdf].Accessed December 2012.
18. Minzi O, Ngaimisi E. Bio-analytical methods for determination of nevirapine in -vivo in resource constrained laboratory. J Chem Pharmacol 2010, 2(2):431-439.
19. Michel D, Marielle B, Gilles P, Evelyne K, Lionel P, Henri P. Low trough plasma concentration of nevirapine associated with virological rebound in HIV infected patient. Ann Pharmacother 2005, 39:603-609. 10.1345/aph.1E563, 15713788.
20. Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Musoke P. Adherence to antiretroviral therapy in children attending Mulago Hospital Kampala. Ann Trop Paediatr 2007, 27:123-131. 10.1179/146532807X192499, 17565809.
21. Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J. Intermittent preventive treatment of malaria in pregnancy. Malar J 2005, 4:31. 10.1186/1475-2875-4-31, 1187919, 16033639.
22. Ngaimisi E, Mugusi S, Minzi O, Sasi P, Riedel KD, Suda A, Janab M, Haefeli WE, Aklillu E. Long-term Efavirenz Autoinduction and its effect on plasma exposure in HIV patients. Clin Pharmacol Ther 2010, 88(5):676-684. 10.1038/clpt.2010.172, 20881953.